top of page

RARE DISEASE DAY 2025: Accelerating Access, Transforming Lives

Today, we stand in solidarity with over 300 million people worldwide living with rare diseases. At Pro Pharmaceuticals Group, we recognise the challenges patients face in accessing life-saving treatments.


As a trusted partner in hospital and named patient supplies, we are committed to bridging the gap in access to specialty medicines, supporting hospitals and healthcare providers in sourcing critical treatments, and working closely with regulators and global partners to ensure timely access.


Every patient deserves a chance at better health. On Rare Disease Day, we reaffirm our mission:

"Accelerating Access, Transforming Lives."


ree

 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

TEL:

1300 077 674 (1300 0 PRO PG)

FAX:

(03) 86790397

AUSTRALIA​      |  GERMANY  |      POLAND

Legal & Trademark Notice
© 2025 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page